Injective INJ
Current Price
$4.46 +5.11%
$0.2400 Daily Range (5.38%)
$4.25$4.49
$38.08M Daily Volume
432 BTC
Vol/MktCap: 8.55%
Market Performance
0.07% Relative BTC Volume
The total volume of Injective is $38.08M over the past 24 hours, compared to $51.62B total Bitcoin volume.
Hourly Moving Average
8 SMA $4.42 +0.88%
13 SMA $4.41 +1.05%
21 SMA $4.38 +1.85%
55 SMA $4.44 +0.37%
144 SMA $4.55 -1.90%
Price Performance
+0.53% 1 Hour Change
$4.46 from $4.44
-7.16% 7 Day Change
-$0.3193 from $4.78
-11.59% 14 Day Change
-$0.5167 from $4.98
-5.52% 30 Day Change
-$0.2461 from $4.71
All Time High
March 14, 2024
$52.62 -91.52%
-$48.16 vs. now
24H Change
19.48M USD +4.57%
221 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
8.71M INJ
traded over past 24 hours
8.71% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $4.42, reflecting a 3.64% increase over the past 24 hours. The trading range during this period has been tight, with a high of $4.49 and a low of $4.24, indicating moderate volatility.
The 24-hour trading volume stands at approximately $38.9 million, contributing to a volume-to-market cap ratio of 8.78%. This suggests a healthy level of trading activity relative to its market capitalization, which could support further price movements.
Analyzing moving averages reveals mixed signals; the 8-day SMA is at $4.42 with a slight decline, while the 13-day SMA indicates a slight increase at $4.41. The longer-term SMAs, particularly the 55-day at $4.44 and the 144-day at $4.55, show a downward trend, highlighting potential resistance levels that may hinder upward momentum.
The 1-hour RSI is at 60, indicating bullish short-term momentum, while the 7-day RSI at 49 suggests a neutral position with respect to medium-term trends. However, both the 7-day and 14-day price changes are negative, with declines of 9.01% and 12.78%, respectively, signaling bearish pressure in the recent past.
Injective’s all-time high of $52.62 remains a significant distance away, indicating the potential for a recovery rally but also reflecting the current struggle to regain previous highs. The combination of recent price performance and RSI levels suggests the asset may need a catalyst to break through resistance and sustain upward movement.
In conclusion, the current price action shows a short-term bullish sentiment, but mixed signals from moving averages and negative medium-term price changes indicate caution. Given these factors, I recommend a Hold rating on Injective (INJ) at this time, as the market may need further confirmation of strength before initiating new buy positions.
The 24-hour trading volume stands at approximately $38.9 million, contributing to a volume-to-market cap ratio of 8.78%. This suggests a healthy level of trading activity relative to its market capitalization, which could support further price movements.
Analyzing moving averages reveals mixed signals; the 8-day SMA is at $4.42 with a slight decline, while the 13-day SMA indicates a slight increase at $4.41. The longer-term SMAs, particularly the 55-day at $4.44 and the 144-day at $4.55, show a downward trend, highlighting potential resistance levels that may hinder upward momentum.
The 1-hour RSI is at 60, indicating bullish short-term momentum, while the 7-day RSI at 49 suggests a neutral position with respect to medium-term trends. However, both the 7-day and 14-day price changes are negative, with declines of 9.01% and 12.78%, respectively, signaling bearish pressure in the recent past.
Injective’s all-time high of $52.62 remains a significant distance away, indicating the potential for a recovery rally but also reflecting the current struggle to regain previous highs. The combination of recent price performance and RSI levels suggests the asset may need a catalyst to break through resistance and sustain upward movement.
In conclusion, the current price action shows a short-term bullish sentiment, but mixed signals from moving averages and negative medium-term price changes indicate caution. Given these factors, I recommend a Hold rating on Injective (INJ) at this time, as the market may need further confirmation of strength before initiating new buy positions.
Updated 86 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

US Bitcoin miners cut output during Winter Storm Fern as network hashrate dips
Bitcoin mining output fell across major US firms during Winter Storm Fern as grid pressure prompted power curtailments.

MEXC and Ether.fi’s Crypto Card ‘Puts Power in the Hands of Users’
The new card can be used at more than 150 million Visa merchants globally, and offers 4% cashback and exclusive perks.

Cathie Wood’s ARK Invest files for two crypto index ETFs tied to CoinDesk 20
One proposed fund will attempt to exactly mimic the CoinDesk 20, but the other would track the index, excluding bitcoin.

Bitcoin, Ethereum ETFs Bleed as Crypto Funds Lose $1.73 Billion, Largest Since November
Digital asset investment products saw $1.73 billion in outflows last week as U.S.-led redemptions intensified.